Leonides Bermejo, MD
Neurology · Hot Springs, ARNPI 1821319989
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 163 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $671 and has fallen 80.1% since, to $133 in 2025.
Across 163 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$439
- Amgen$394
- Amneal Pharmaceuticals LLC$393
- Novartis$307
- AstraZeneca$300
- Sunovion Pharmaceuticals Inc.$246
- plus $1K from 24 others
What the payments were for
- Speaking & faculty fees$1254%
- Food & beverage$3,12696%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 25 | $439 |
| Amgen | 22 | $394 |
| Amneal Pharmaceuticals LLC | 23 | $393 |
| Novartis | 18 | $307 |
| AstraZeneca | 8 | $300 |
| Sunovion Pharmaceuticals Inc. | 12 | $246 |
| Biogen | 9 | $163 |
| EMD Serono, Inc. | 8 | $146 |
| Biohaven Pharmaceuticals, Inc. | 1 | $124 |
| Sanofi | 6 | $111 |
| SK Life Science, Inc. | 2 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $63 |
| Lilly USA, LLC | 4 | $60 |
| Mallinckrodt Enterprises LLC | 3 | $56 |
| UCB, Inc. | 2 | $55 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $54 |
| Lundbeck LLC | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Livanova USA, Inc. | 1 | $18 |
| Argenx US, Inc. | 1 | $18 |
| Tanabe Pharma America, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| GE HealthCare | 1 | $16 |
| Philips North America LLC | 1 | $16 |
| Bayer | 1 | $15 |
| Neurelis, Inc. | 1 | $15 |
| Pfizer | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYTARY$125
- NURTEC ODT$124
- SOLIRIS$101
How this compares
$3,251 in reported general payments places this provider in the 60th percentile of 93 neurology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Hot Springs
- Kara WayHot Springs$72K
- Edward KramerHot Springs$6K
- Anudeep SurendranathHot Springs$4K
- Richard PellegrinoHot Springs$2K
- Kathryn ChenaultSherwood$532K
- Steve-Felix BelingaFort Smith$183K
- Michael MorseFayetteville$149K
- Mark PippengerNorth Little Rock$109K
- Keith SchlutermanConway$67K
- Shitiz SriwastavaLittle Rock$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.